Browse & search snapshots

Protéger la santé humaine et l'environnement : Engagements de la Direction de la réglementation des pesticides envers la population canadienne La Direction de la réglementation des pesticides de Santé Canada maintient son engagement de protéger la santé humaine et l’environnement…

Consultation paper comparison of national access to medicine regimes Annex B: International Comparison Subject Canada EU Switzerland Norway India China Korea Netherlands Implementing Instrument Patent Act , s.21.01-21.2 Regulation 816/2006 Draft Amendment to Federal Law on…

Submit a certified copy of the importing country's notification under Canada's Access to Medicines Regime An eligible country seeking to import a patented drug or medical device under Canada's Access to Medicine's Regime must submit a notification of its intentions, either to the…

Declaring monetary value and units sold under Canada's Access to Medicines Regime Within 15 days of the day on which the compulsory licence was granted or the supply agreement was signed, whichever is later, the pharmaceutical company must complete and submit to the patent holder…

Declare identity and patent status of pharmaceutical product under Canada's Access to Medicines Regime The pharmaceutical company must complete and submit to the Commissioner of Patents one of the forms listed below. The company should choose the form that corresponds to the…

Declaring an attempt at negotiating a voluntary licence under Canada's Access to Medicines Regime The pharmaceutical company must complete and submit to the Commissioner of Patents a Solemn or Statutory Declaration Under Paragraph 21.04(3)( c ) of the Patent Act . The form sets…

Apply for authorization form under Canada's Access to Medicines Regime The pharmaceutical company must complete and submit to the Commissioner of Patents an Application for Authorization Under Section 21.04 of the Patent Act . The form sets out the information that must appear in…

Process map for preparing to submit an application under Canada's Access to Medicines Regime This process map provides a visual overview of the steps that need to be followed by a pharmaceutical company that is preparing to submit an application for a compulsory licence under…

Process map of terms and conditions of a compulsory licence under Canada's Access to Medicines Regime This process map provides a visual overview of the steps that need to be followed by a pharmaceutical company to meet the terms and conditions of a compulsory licence under…

The terms and conditions are outlined below, with links to more detailed information: Comply with the Conditions of Compulsory Licences and Anti-diversionary Measures .